<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> is a significant health problem, and the advanced stages of the disease have a low response rate to chemotherapy and easily acquire chemoresistance </plain></SENT>
<SENT sid="1" pm="."><plain>HIV-1 <z:mp ids='MP_0001799'>viral</z:mp> protein R (Vpr) has been shown to possess inhibitory effects on various malignant cells in vivo and in vitro </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, an Ad-Vpr construct was used to infect the multidrug-resistant human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> HCT-8/5-FU(<z:chebi fb="14" ids="53218">MDR</z:chebi>) cell line in vitro for cell viability, <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, gene expression and gene activity using the <z:chebi fb="0" ids="53233">MTT</z:chebi>, flow cytometry, immunoblotting and gel shift assays, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>The data showed that Ad-Vpr significantly reduced HCT-8/5-FU(<z:chebi fb="14" ids="53218">MDR</z:chebi>) cell viability in a dose- and time-dependent manner </plain></SENT>
<SENT sid="4" pm="."><plain>Ad-Vpr <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> promoted HCT-8/5-FU(<z:chebi fb="14" ids="53218">MDR</z:chebi>) cells to undergo <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and to arrest at the G2 phase of the cell cycle </plain></SENT>
<SENT sid="5" pm="."><plain>The G2 cell cycle protein Cyclin B1 accumulated in the cells after Ad-Vpr <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, Ad-Vpr induced activation of caspase-3 and -9, but not caspase-8, in HCT-8/5-FU(<z:chebi fb="14" ids="53218">MDR</z:chebi>) cells </plain></SENT>
<SENT sid="7" pm="."><plain>Ad-Vpr suppressed expression of the Bcl-xl protein, but upregulated Bax expression and <z:chebi fb="1" ids="18070">cytochrome c</z:chebi> release from the mitochondria in HCT-8/5-FU(<z:chebi fb="14" ids="53218">MDR</z:chebi>) cells </plain></SENT>
<SENT sid="8" pm="."><plain>Ad-Vpr <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> also resulted in a time-dependent decrease in nuclear translocation of NF-��B/p65 protein and p65 DNA-binding activity in HCT-8/5-FU(<z:chebi fb="14" ids="53218">MDR</z:chebi>) cells </plain></SENT>
<SENT sid="9" pm="."><plain>The data from the current study provide mechanistic insights into understanding the molecular basis and utility of Ad-Vpr as a novel anticancer agent for multidrug resistance in human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>